Log in to your Inderes Free account to see all free content on this page.
Immunovia
0.17 SEK
-0.81 %
Less than 1K followers
IMMNOV
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Immunovia
EV/S
Median 2019-2024
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | 64.38 | 42.73 | 26.89 | 9.43 | 0.68 | 0.42 | 0.23 |
| Shares | 54.6 | 59.5 | 63.1 | 63.1 | 117.2 | 218.3 | 672.7 |
| Market cap | 3,514.6 | 2,543.7 | 1,697.4 | 595.2 | 80.2 | 92.7 | 152.7 |
| Enterprise value | 3,289.3 | 2,108.4 | 1,443.3 | 526.7 | 13.7 | 68.0 | - |
| EV/S | 9,239.6 | 5,824.3 | 1,710.0 | 458.0 | 8.7 | 73.1 | - |
| EV/EBITDA | neg. | neg. | neg. | neg. | neg. | neg. | - |
| EV/EBIT | neg. | neg. | neg. | neg. | neg. | neg. | - |
| P/E | neg. | neg. | neg. | neg. | neg. | neg. | neg. |
| P/B | 9.83 | 4.24 | 3.91 | 2.44 | 1.20 | 7.95 | 2.36 |
| P/S | 9,872.5 | 7,026.9 | 2,011.1 | 517.6 | 50.8 | 99.6 | 222.9 |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 85.3 % | 90.7 % | 87.9 % | 81.1 % | 67.9 % | 35.3 % | 73.4 % |
| Gearing ratio | 10.6 % | 5.5 % | 7.7 % | 15.4 % | 15.3 % | 5.8 % | 1.3 % |
Login required
This content is only available for logged in users